Safety Profile of Daclizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.469
https://www.valueinhealthjournal.com/article/S1098-3015(16)31836-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
442
First Page :
A427
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31836-8&doi=10.1016/j.jval.2016.09.469